There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Armata Pharmaceuticals (ARMP) with bullish sentiments.
Armata Pharmaceuticals (ARMP)
Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on Armata Pharmaceuticals on March 18 and set a price target of $9.00. The company’s shares closed last Friday at $4.91.
According to TipRanks.com, Higgins is a 4-star analyst with an average return of 15.5% and a 37.1% success rate. Higgins covers the Healthcare sector, focusing on stocks such as Eiger Biopharmaceuticals, Zynerba Pharmaceuticals, and Rhythm Pharmaceuticals.
Armata Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $7.33, representing a 44.9% upside. In a report issued on March 13, Brookline Capital Markets also initiated coverage with a Buy rating on the stock with a $9.00 price target.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
